CVS Health (CVS) insider buying

Healthcare · Healthcare Plans · Market cap $109.7B

9 open-market purchases of CVS by CVS Health's executives and directors since June 2025, worth $100,009 in total, from SEC Form 4 filings.

The most recent: Michael T. Mccaul bought — on February 20, 2026.

The biggest buyer over the period is Guy P Sansone: 1 purchase, $100,009.

By year

YearPurchasesValue
20264$0
20255$100,009

Biggest buyers

InsiderBuysValue
Guy P Sansone
1$100,009
Michael T. Mccaul
2$0
John Boozman
2$0
Lisa C. Mcclain
2$0
Ro Khanna
2$0

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Feb 20, 2026 Michael T. Mccaul
0$76.64— —
Feb 20, 2026 Michael T. Mccaul
0$76.64— —
Jan 29, 2026 John Boozman
0$74.33— —
Jan 29, 2026 John Boozman
0$74.33— —
Oct 30, 2025 Lisa C. Mcclain
0$76.70— —
Oct 30, 2025 Lisa C. Mcclain
0$76.70— —
Aug 4, 2025 Ro Khanna
0$61.45— —
Aug 4, 2025 Ro Khanna
0$61.45— —
Jun 5, 2025 Guy P Sansone
1,570$63.70$100,009 Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for CVS.
Open CVS in Investingly

Questions

Are CVS Health insiders buying the stock?

9 open-market purchases of CVS by CVS Health's executives and directors since June 2025, worth $100,009 in total, from SEC Form 4 filings. The most recent: Michael T. Mccaul bought — on February 20, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From CVS Health's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.